ACCO BRANDS Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ACCO BRANDS Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,557	1,949	1,941	1,956	1,655	2,025	1,948	1,833	1,666	1,525
Cost of revenue	1,042	1,292	1,313	1,322	1,163	1,410	1,395	1,235	1,111	1,025
Gross profit	515	657	628	634	492	615	552	598	555	500
Research and development	21	23.5	23.8	21.8	19.7	26.6	26.3	25.8	23	22
Selling, general and administrative	329	416	392	390	336	393	377	394	366	347
Selling and marketing							222	218	207	201
General and administrative							114	128	117	106
Operating expenses	356	473	441	437	380	464	518	554	592	408
Operating income	159	185	187	196	112	151	34.8	44.7	-37	92.3
Interest expense	49.3	41.1	41.2	43.2	38.8	46.3	45.6	58.6	52.6	45.8
Interest income	6.4	5.8	4.4	3.2	1	1.9	8.3	7.1	7.5	9.4
Other non-operating income	-1.4	0.4	-1.6	1.8	-1.6	-3.1	12.9	-4.5	0.9	-4.3
Pre-tax income	125	158	158	164	78.6	111	14.9	-13.1	-87.3	49.1
Income tax	29.6	24	51.2	56.7	16.6	9.5	28.1	8.7	14.3	7.8
Net income	95.5	132	107	107	62	102	-13.2	-21.8	-102	41.3
EBITDA	190	220	221	231	150	190	72.7	77.4	-8.6	119
EPS, basic	0.89	1.22	1.02	1.07	0.65	1.07	-0.14	-0.23	-1.06	0.45
EPS, diluted	0.87	1.19	1.00	1.06	0.65	1.05	-0.14	-0.23	-1.06	0.44
Shares, basic (weighted)	107	108	105	99.5	94.9	95.5	95.3	95.3	95.6	92.1
Shares, diluted (weighted)	109	111	107	101	96.1	97.1	95.3	95.3	95.6	94
Dividend per share			0.24	0.25	0.26	0.27	0.30	0.30	0.30	0.30

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	42.9	76.9	67	27.8	36.6	41.2	62.2	66.4	74.1	64.4
Receivables	391	469	428	454	356	416	384	431	349	360
Inventory	210	254	341	283	305	428	395	328	270	289
Other current assets	26.8	29.2	44.2	41.2	30.5	39.6	40.8	30.8	38.1	37.1
Total current assets	671	830	880	806	728	925	882	855	732	750
Property, plant and equipment	198	279	264	267	241	215	185	170	138	139
Lease right-of-use assets			0	102	89.2	105	88.8	91	81	78
Goodwill	587	670	709	719	827	803	672	590	446	479
Intangible assets	566	840	787	759	977	902	847	816	710	697
Other non-current assets	15.3	42.9	31.5	17.4	49	26	20.3	17.9	33.1	17.7
Total assets	2,065	2,799	2,786	2,789	3,049	3,091	2,795	2,645	2,228	2,253
Accounts payable	135	178	275	246	180	308	240	184	167	187
Accrued liabilities	42.8	60.9	41.6	48.5	41	56.9	38.3	53.3	43.2	30.1
Short-term debt	68.5	43.2	39.5	33.2	76.5	43	60	36.7	51.3	30.8
Total current liabilities	406	538	599	589	557	709	589	542	490	465
Long-term debt	628	889	843	777	1,055	954	937	882	783	806
Lease liabilities			11	89.8	76.5	89	75.2	76.8	66.9	63.5
Other non-current liabilities	77	145	110	98.4	123	95.3	84.3	73.6	52.7	27.3
Total liabilities	1,356	2,025	1,997	2,015	2,306	2,227	1,985	1,858	1,622	1,588
Total debt	633	932	883	807	1,125	988	986	919	824	837
Paid-in capital	2,016	2,000	1,941	1,891	1,883	1,902	1,897	1,913	1,912	1,909
Retained earnings	-872	-739	-657	-574	-537	-462	-504	-556	-688	-675
Treasury stock	-17	-26.4	-33.9	-38.2	-39.9	-40.9	-43.4	-45.1	-47	-47.9
Other comprehensive income	-419	-461	-462	-506	-564	-536	-540	-526	-572	-523
Shareholders' equity	709	774	790	774	743	865	810	787	606	665
Total equity	709	774	790	774	743	865	810	787	606	665
Total liabilities and equity	2,065	2,799	2,786	2,789	3,049	3,091	2,795	2,645	2,228	2,253
Shares outstanding	108	107	103	96.4	94.9	95.8	94.3	94.9	92.9	90.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	95.5	132	107	107	62	102	-13.2	-21.8	-102	41.3
Depreciation and amortization	30.4	35.6	34	34.9	37.9	39.4	37.9	32.7	28.4	26.6
Stock-based compensation	19.4	17	8.8	10.1	6.5	15.2	9.5	14.8	11.9	11.5
Deferred income tax	6	-45.2	22.7	8.7	-7.6	-21	1.3	-20.1	-6.9	-3.5
Change in receivables	13.4	10.2	46	-14.8	102	-77.6	31.6	-38.6	43.3	5.2
Change in inventory	16.7	2.5	-92.9	71.4	2.2	-132	23.2	85.5	38.3	1.1
Change in payables	-19.3	-18.7	101	-32.8	-68.8	131	-66	-68	-6.3	10
Cash from operations	167	205	195	204	119	160	77.6	129	148	68.7
Capital expenditures	-18.5	-31	-34.1	-32.8	-15.3	-21.2	-17.7
Acquisitions	-88.8	-292	-38	-41.3	-339	15.4	0	0	0	-10.1
Cash from investing	-106	-319	-71.9	-79.6	-355	-5.8	-9.3	-11.2	-12.3	-9.3
Debt issued	587	484	225	326	439	660	237	122	207	165
Debt repaid	-685	-297	-250	-388	-152	-766	-221	-199	-293	-185
Stock issued	6.8	4.2	6.8	4.2	4.4	3.1	4.3	0	0
Share buybacks	0	-36.6	-75	-65	-18.9	0	-19.4	0	-15	-15.1
Dividends paid	0	0	-25.1	-24.4	-24.6	-25.8	-28.6	-28.5	-28.4	-27
Cash from financing	-76.4	142	-126	-163	245	-147	-48.3	-118	-123	-76.7
Exchange rate effect	3.2	6	-7.2	-0.1	-0.4	-2	1	4.4	-5.6	7.6
Net change in cash	-12.5	34	-9.9	-39.2	8.8	4.6	21	4.2	7.7	-9.7
Free cash flow	149	174	161	171	104	138	59.9
Interest paid	50.1	38	37.9	42.1	36	37.6	42.6	55.6	49.4	43.3
Income taxes paid	16.9	34.8	33.7	41.9	32.2	28	37.5	44.3	41.6	35.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.31 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.6%	Gross profit / revenue.
Operating margin	5.5%	Operating income / revenue.
EBITDA margin	6.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.9%	Pre-tax income / revenue.
Net margin	3.7%	Net income / revenue.
Operating cash flow margin	4.5%	Cash from operations / revenue.
Effective tax rate	24.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.5%	Net income / average total assets.
Return on invested capital (ROIC)	4.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	23.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	1.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-8.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-7.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-10.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	0.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	38.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-3.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	17.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-4.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 5y	-7.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 5y	-7.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-53.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-4.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-10.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	2.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	9.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-6.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-2.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-6.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.97x	Current assets / current liabilities.
Quick ratio	1.10x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.24x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.33x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	39.5%	Total debt / total assets.
Liabilities / assets	70.3%	Total liabilities / total assets.
Net debt	$811.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	7.47x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.87x	Operating income / interest expense.
Working capital	$423.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	49.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$453.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.68x	Revenue / average total assets.
Fixed asset turnover	11.5x	Revenue / average property, plant and equipment.
Inventory turnover	3.23x	Cost of revenue / average inventory.
Days inventory	113 days	365 x average inventory / cost of revenue.
Receivables turnover	4.20x	Revenue / average receivables.
Days sales outstanding	87 days	365 x average receivables / revenue.
Days payables	58 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	142 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.62	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$16.44	Revenue / diluted weighted shares.
Operating cash flow per share	$0.74	Cash from operations / diluted weighted shares.
Book value per share	$7.49	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$4.91	Tangible book value / shares outstanding.
Cash per share	$1.15	(Cash + short-term investments) / shares outstanding.
Payout ratio	46.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$397.8M	Share price x shares outstanding.
Enterprise value	$1.21B	Market cap + total debt - cash - short-term investments.
P/E	6.77x	Market cap / net income. Only when net income is positive.
P/S	0.25x	Market cap / revenue.
P/B	0.58x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	5.66x	Market cap / cash from operations, when positive.
EV/Sales	0.77x	Enterprise value / revenue.
EV/EBIT	14.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.1x	Enterprise value / EBITDA, when both are positive.
Earnings yield	14.8%	Net income / market cap (the inverse of P/E).
Dividend yield	6.9%	Dividends paid over the period / market cap.
Shareholder yield	6.9%	(Dividends paid + share buybacks) / market cap.

What was ACCO BRANDS Corp's revenue in fiscal 2025?

ACCO BRANDS Corp reported revenue of $1.52B for fiscal 2025, 8.5% lower than the year before.

Was ACCO BRANDS Corp profitable in fiscal 2025?

Yes. Net income was $41.3M, a net margin of 2.7%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ACCO BRANDS Corp